Opiod Use Disorder

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Delpor
DelporCA - Brisbane
1 program
1
Combination Product: NaltrexonePhase 11 trial
Active Trials
NCT05304364CompletedEst. Nov 2022

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
DelporCombination Product: Naltrexone

Clinical Trials (1)

NCT05304364DelporCombination Product: Naltrexone

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)

Start: Mar 2022Est. completion: Nov 2022
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space